Enhurtu (fam-trastuzumab deruxtecan-nxki) HER2 in Gastroesophageal Cancer Gastrointestinal 5 Mins Read4 The DESTINY-Gastric02 study is a very important study because it’s the first study in western patients with HER2 positive Gastric…
